Avidity Biosciences
RNAM
#1786
Rank
C$16.13 B
Marketcap
C$104.42
Share price
0.00%
Change (1 day)
47.15%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Last known market cap: C$16.13 Billion

As of November 2026 Avidity Biosciences has a market cap of C$16.13 Billion. This makes Avidity Biosciences the world's 1786th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026C$16.13 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
C$223.95 B 1,288.34%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$137.28 B 751.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C$2.04 B-87.29%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
C$6.75 B-58.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.16 B-99.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
C$1.17 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
C$15.67 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$5.52 B-65.73%๐Ÿ‡บ๐Ÿ‡ธ USA